Skip to main content

PGD conditions

This table shows all PGD conditions currently approved and awaiting consideration by the HFEA.

Please note that we are updating this database, and some approved conditions may not be displayed. If you are unsure if a condition has been approved or not, please contact

Condition name Status OMIM number Documents
Focal Segmental Glomerulosclerosis Type 5 approved 613237
Focal Segmental Glomerulosclerosis Type 6 approved 614131
Focal Segmental Glomerulosclerosis Type 8 approved 615032
Focal Segmental Glomerulosclerosis Type 9 approved 616220
Fontaine Progeroid Syndrome (FPS) approved 612289
Fragile X Syndrome (FRAX) approved 300624
Fragile XE syndrome (FRAXE) approved 309548
Fraser Syndrome approved 219000
Friedreich Ataxia 1 (FRDA) approved 229300
Frontometaphyseal Dysplasia approved 305620
Frontotemporal Dementia approved 600274
Frontotemporal dementia and/or amyotrophic lateral sclerosis 2 approved 615911
Frontotemporal dementia and/or Amyotrophic lateral sclerosis 3 approved 616437
Frontotemporal dementia and/or Amyotrophic lateral sclerosis 4 approved 616439
Galactosaemia approved 230400
Galactosialidosis (early infantile and adult / juvenile types) (GSL) approved 256540
Gangliosidosis (GM1) approved 230500
Gaucher Disease Type II approved 230900
Gaucher Disease Type III approved 231000
Gerstmann-Straussler-Scheinker syndrome approved 137440